These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 11252157)
1. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. Turchan J; Anderson C; Hauser KF; Sun Q; Zhang J; Liu Y; Wise PM; Kruman I; Maragos W; Mattson MP; Booze R; Nath A BMC Neurosci; 2001; 2():3. PubMed ID: 11252157 [TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. Maragos WF; Young KL; Turchan JT; Guseva M; Pauly JR; Nath A; Cass WA J Neurochem; 2002 Nov; 83(4):955-63. PubMed ID: 12421368 [TBL] [Abstract][Full Text] [Related]
3. Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism. Kendall SL; Anderson CF; Nath A; Turchan-Cholewo J; Land CL; Mactutus CF; Booze RM BMC Neurosci; 2005 Jun; 6():40. PubMed ID: 15943860 [TBL] [Abstract][Full Text] [Related]
4. 17beta-estradiol protects SH-SY5Y Cells against HIV-1 gp120-induced cell death: evidence for a role of estrogen receptors. Russo R; Navarra M; Maiuolo J; Rotiroti D; Bagetta G; Corasaniti MT Neurotoxicology; 2005 Oct; 26(5):905-13. PubMed ID: 15899520 [TBL] [Abstract][Full Text] [Related]
5. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl. Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650 [TBL] [Abstract][Full Text] [Related]
6. Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons. Aksenov MY; Aksenova MV; Silvers JM; Mactutus CF; Booze RM Neurotoxicology; 2008 Nov; 29(6):971-7. PubMed ID: 18606182 [TBL] [Abstract][Full Text] [Related]
7. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Nath A; Haughey NJ; Jones M; Anderson C; Bell JE; Geiger JD Ann Neurol; 2000 Feb; 47(2):186-94. PubMed ID: 10665489 [TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol. D'Astous M; Gajjar TM; Dluzen DE; Di Paolo T Neuroendocrinology; 2004; 79(6):296-304. PubMed ID: 15249736 [TBL] [Abstract][Full Text] [Related]
9. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Aksenov MY; Aksenova MV; Nath A; Ray PD; Mactutus CF; Booze RM Neurotoxicology; 2006 Mar; 27(2):217-28. PubMed ID: 16386305 [TBL] [Abstract][Full Text] [Related]
11. Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins. Rumbaugh JA; Li G; Rothstein J; Nath A J Neurovirol; 2007 Apr; 13(2):168-72. PubMed ID: 17505985 [TBL] [Abstract][Full Text] [Related]
12. Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function. Wallace DR; Dodson S; Nath A; Booze RM Synapse; 2006 Jan; 59(1):51-60. PubMed ID: 16237680 [TBL] [Abstract][Full Text] [Related]
13. Methamphetamine toxicity and its implications during HIV-1 infection. Silverstein PS; Shah A; Gupte R; Liu X; Piepho RW; Kumar S; Kumar A J Neurovirol; 2011 Oct; 17(5):401-15. PubMed ID: 21786077 [TBL] [Abstract][Full Text] [Related]
14. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Theodore S; Cass WA; Maragos WF Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084 [TBL] [Abstract][Full Text] [Related]
16. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum. Loonam TM; Noailles PA; Yu J; Zhu JP; Angulo JA Life Sci; 2003 Jun; 73(6):727-39. PubMed ID: 12801594 [TBL] [Abstract][Full Text] [Related]
17. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia. Giunta B; Obregon D; Hou H; Zeng J; Sun N; Nikolic V; Ehrhart J; Shytle D; Fernandez F; Tan J Brain Res; 2006 Dec; 1123(1):216-225. PubMed ID: 17078933 [TBL] [Abstract][Full Text] [Related]
18. Molecular basis for interactions of HIV and drugs of abuse. Nath A; Hauser KF; Wojna V; Booze RM; Maragos W; Prendergast M; Cass W; Turchan JT J Acquir Immune Defic Syndr; 2002 Oct; 31 Suppl 2():S62-9. PubMed ID: 12394784 [TBL] [Abstract][Full Text] [Related]
19. Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Gao X; Dluzen DE Neuroscience; 2001; 103(2):385-94. PubMed ID: 11246153 [TBL] [Abstract][Full Text] [Related]
20. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. Sawada H; Ibi M; Kihara T; Urushitani M; Akaike A; Shimohama S J Neurosci Res; 1998 Dec; 54(5):707-19. PubMed ID: 9843162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]